Sponsor pipeline

Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company clinical trial pipeline

Get alerts when Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    Start date moved earlier from Oct 23, 2024 to Oct 3, 2024

    Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and CompanyPhase 1 NCT06343805 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1

Disease areas by active trials

Myelofibrosis (1)

Get alerts when Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free